State Street Corp Infinity Pharmaceuticals, Inc. Transaction History

State Street Corp

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$0.14 - $0.24 $1,078 - $1,848	-7,700 Reduced 2.25%	334,360 $70,000
Q3 2022 Nov 15, 2022	BUY	$0.59 - $1.7 $14,101 - $40,630	23,900 Added 7.51%	342,060 $407,000
Q2 2022 Aug 15, 2022	SELL	$0.49 - $1.2 $767,741 - $1.88 Million	-1,566,819 Reduced 83.12%	318,160 $201,000
Q1 2022 May 16, 2022	BUY	$0.85 - $2.4 $73,105 - $206,414	86,006 Added 4.78%	1,884,979 $2.15 Million
Q4 2021 Feb 14, 2022	BUY	$1.86 - $3.36 $170,658 - $308,286	91,752 Added 5.37%	1,798,973 $4.05 Million
Q3 2021 Nov 15, 2021	BUY	$1.52 - $3.82 $481,113 - $1.21 Million	316,522 Added 22.76%	1,707,221 $5.84 Million
Q2 2021 Aug 16, 2021	BUY	$2.66 - $3.47 $3.55 Million - $4.63 Million	1,333,110 Added 2314.87%	1,390,699 $4.16 Million
Q1 2021 May 17, 2021	BUY	$1.98 - $5.36 $4,554 - $12,328	2,300 Added 4.16%	57,589 $186,000
Q1 2020 May 11, 2020	BUY	$0.69 - $1.52 $38,149 - $84,039	55,289 New	55,289 $46,000

1.26M

Ticker INFI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 89,277,904
Description
Infinity Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing novel medicines for people with cancer. Its product candidate is IPI-549, an orally administered clinical-stage immuno-oncology product candidate that inhibits the enzyme phosphoinositide-3-kinase-gamma, which is in Phase 2 clinical trials for the treatment of met...

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

Stay updated on State Street Corp with notifications on news.